Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (25,199)	$ (47,864)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	13,677	13,176
Bad debt expense and other reserves	510	465
Stock-based compensation	8,774	11,872
Increase in the fair value of contingent consideration liability	281	771
Amortization of lease right-of-use assets	642	2,350
Impairment of right-of-use assets	6,880	2,376
Other noncash expense	781	382
Changes in operating assets and liabilities:
Accounts receivable	1,232	(725)
Prepaid expenses and other assets	(2,245)	1,471
Accounts payable	820	1,254
Accrued employee expenses	(1,566)	742
Operating lease liabilities	(3,072)	(3,173)
Accrued expenses and other current liabilities	331	245
Other liabilities	0	43
Net cash provided by (used in) operating activities	1,846	(16,615)
Cash flows from investing activities
Purchase of property and equipment	(6,151)	(9,469)
Net cash used in investing activities	(6,151)	(9,469)
Cash flows from financing activities
Payment for Contingent Consideration Liability, Financing Activities	(1,610)	(1,908)
Proceeds from exercise of common stock options	61	502
Taxes paid related to net share settlement of equity awards	(2,608)	(2,554)
Payments for the repurchase of common stock	(13,993)	0
Net cash used in financing activities	(18,150)	(3,960)
Net decrease in cash, cash equivalents and restricted cash	(22,455)	(30,044)
Cash, cash equivalents and restricted cash at beginning of period	114,509	145,474
Cash, cash equivalents and restricted cash at end of period	136,964	175,518
Supplemental disclosures of non-cash activities
Stock-based compensation capitalized for software development	554	651
Capitalized assets included in accounts payable, accrued employee expenses and other accrued expenses	$ 779	$ 1,009